EULAR recommendations for the management of knee osteoarthritis. Report ofa task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials
B. Mazieres et al., EULAR recommendations for the management of knee osteoarthritis. Report ofa task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials, JOINT BONE, 68(3), 2001, pp. 231-240
A task force for the EULAR standing committee for clinical trials determine
d the methodological and logistical approach required for the development o
f evidence-based guidelines for treatment of knee osteoarthirits (OA). Meth
ods. The first stage was the selection of treatment modalities to be consid
ered. The second stage comprised a search of the databases of all European-
language publications. All of the relevant studies were quality scored. The
third stage involved determination of key clinical propositions by expert
consensus employing a Delphi approach. The final stage involved ranking of
these propositions according to the available evidence. A second set of pro
positions relating to a future research agenda was determined by expert con
sensus. Results. Seven hundred and forty-four studies presented outcome dat
a of the effects of specific treatments on knee OA. Quantitative analysis o
f treatment effect was possible in only 61 studies. Recommendations for the
management of knee OA based on currently available data and expert opinion
are presented. Proposals for a future research agenda are highlighted. Con
clusions. These are the first clinical guidelines on knee OA to combine an
evidence-based approach and a consensus approach across a wide range of tre
atment modalities. It is apparent that only certain clinical propositions a
re supported by substantial research-based evidence. There is thus an urgen
t need for future well-designed trials to address key clinical questions. J
oint Bone Spine 2001 ; 68 : 231-40. (C) 2001 Editions scientifques et medic
ales Elsevier SAS.